Mersana Therapeutics, Inc. (NASDAQ:MRSN) Not Doing Enough For Some Investors As Its Shares Slump 34%

Mersana Therapeutics, Inc. (NASDAQ:MRSN) shares have had a horrible month, losing 34% after a relatively good period beforehand.

Simply Wall StApr 26 18:32

Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS

BenzingaApr 25 01:57

Mersana Therapeutics (NASDAQ:MRSN Investor Three-year Losses Grow to 80% as the Stock Sheds US$68m This Past Week

While not a mind-blowing move, it is good to see that the Mersana Therapeutics, Inc. (NASDAQ:MRSN) share price has gained 20% in the last three months. But the last three years have seen a terrible

Simply Wall StApr 20 20:06

Daily rights tracking | Trump's media rose 40% in two days! Earn eight times the option premium with a single call

Tesla's multiple single options due today doubled and surged; TSMC options trading volume surged by nearly 60%, slightly rising to 68% from a bullish ratio.

Futu NewsApr 19 17:03

Daily ticket tracking | Big users are feverishly hoarding call lists! Meta's bullish ratio is already over 70%

Intel plummeted more than 5% last Friday, and options transactions rose to 430,000. The 33-dollar deposit due this Friday earned six times the premium; J.P. Morgan's stock price fell more than 6% after the results, and options trading volume surged to nearly 3 times the average daily turnover.

Futu NewsApr 15 17:03

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates

GlobeNewswireApr 5 04:30